Allscripts Healthcare Solutions Inc

NASDAQ:MDRX  
17.53
+2.08 (+13.46%)
Other Pre-Announcement

Allscripts Announces Second Quarter Of 2022 Results

Published: 08/04/2022 20:58 GMT
Allscripts Healthcare Solutions Inc (MDRX) - Allscripts Announces Second Quarter of 2022 Results.
Q2 Bookings of $107 Million.
Q2 2022 Veradigm Revenue Was $145 Million Compared With $133 Million.
Sees FY Veradigm Revenue Growth Year-over-year Between 6% to 7%.
Qtrly Loss per Share $0.57 ; Qtrly Adjusted Loss per Share $0.54.
Q2 Earnings per Share View $0.15, Revenue View $147.3 Million -- Refinitiv Ibes Data (analyst estimates).